AR and urinary bladder cancer: In contrast, in bladder cancer targeting AR enhances NK activity decreasing PD-L1 expression; both anti-androgen treatment and knockdown significantly reduced PD-L1 expression and stimulated NK cell-mediated bladder cancer cell death by downregulating circRNA circ_0001005 (113).